{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:40:00Z","timestamp":1788968400554,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2016M592825"],"award-info":[{"award-number":["2016M592825"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shaanxi State Ministry of Health","award":["2016D044"],"award-info":[{"award-number":["2016D044"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.intimp.2017.07.003","type":"journal-article","created":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T20:30:28Z","timestamp":1501705828000},"page":"31-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Psoralidin suppresses osteoclastogenesis in BMMs and attenuates LPS-mediated osteolysis by inhibiting inflammatory cytokines"],"prefix":"10.1016","volume":"51","author":[{"given":"Lingbo","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baorong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingjun","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.intimp.2017.07.003_bb0005","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1593","article-title":"Skeletal remodeling in health and disease","volume":"13","author":"Zaidi","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2017.07.003_bb0010","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrg1122","article-title":"Genetic regulation of osteoclast development and function","volume":"4","author":"Steven","year":"2003","journal-title":"Nat. Rev."},{"key":"10.1016\/j.intimp.2017.07.003_bb0015","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.289.5484.1508","article-title":"Therapeutic approaches to bone diseases","volume":"289","author":"Rodan","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.intimp.2017.07.003_bb0020","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.bone.2007.05.016","article-title":"Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells","volume":"41","author":"Mohamed","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.intimp.2017.07.003_bb0025","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2017.07.003_bb0030","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1084\/jem.190.12.1741","article-title":"Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors","volume":"190","author":"Arai","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2017.07.003_bb0035","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/edrv.20.3.0367","article-title":"Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families","volume":"20","author":"Suda","year":"1999","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.intimp.2017.07.003_bb0040","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/emboj\/20.6.1271","article-title":"Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis","volume":"20","author":"Kobayashi","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.intimp.2017.07.003_bb0045","doi-asserted-by":"crossref","first-page":"47366","DOI":"10.1074\/jbc.M208284200","article-title":"U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells","volume":"277","author":"Hotokezaka","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2017.07.003_bb0050","doi-asserted-by":"crossref","first-page":"26475","DOI":"10.1074\/jbc.M313973200","article-title":"Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos","volume":"279","author":"Matsuo","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2017.07.003_bb0055","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.fitote.2003.12.018","article-title":"Antibac-terial compounds from the seeds of Psoralea corylifolia","volume":"75","author":"Khatune","year":"2004","journal-title":"Fitoterapia"},{"key":"10.1016\/j.intimp.2017.07.003_bb0060","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.555","article-title":"Psoralidin induces autophagy through ROS generation which inhibits the proliferation of human lung cancer A549 cells","volume":"2","author":"Hao","year":"2014","journal-title":"PeerJ"},{"key":"10.1016\/j.intimp.2017.07.003_bb0065","doi-asserted-by":"crossref","first-page":"6449","DOI":"10.3390\/molecules17066449","article-title":"The coumarin psoralidin enhances anticancer effect of tumor necrosis factor-related apopto- sis-inducing ligand (TRAIL)","volume":"17","author":"Bronikowska","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2017.07.003_bb0070","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF02978259","article-title":"Cytotoxic constituents of Psoralea corylifolia","volume":"24","author":"Mar","year":"2001","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.intimp.2017.07.003_bb0075","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1158\/1940-6207.CAPR-08-0129","article-title":"Psoralidin, an herbal molecule, inhibits phosphatidylinositol 3-kinase-me- diated Akt signaling in androgen-independent prostate cancer cells","volume":"2","author":"Kumar","year":"2009","journal-title":"Cancer Prev. Res. (Phila.)"},{"issue":"109","key":"10.1016\/j.intimp.2017.07.003_bb0080","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejphar.2010.10.004","article-title":"Psoralidin inhibits LPS-induced iNOS expression via repressing Syk-mediated activation of PI3K-IKK-IkappaB signaling pathways","volume":"650","author":"Chiou","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2017.07.003_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061013","article-title":"Pyrroloquinoline quinine inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos in mouse bone marrow cells and inhibits wear particle-induced osteolysis in mice","volume":"8","author":"Kong","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.intimp.2017.07.003_bb0090","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0890-5096(06)60771-1","article-title":"Carotid plaque morphology: correlation of duplex sonography with histology","volume":"2","author":"Bendick","year":"1988","journal-title":"Ann. Vasc. Surg."},{"key":"10.1016\/j.intimp.2017.07.003_bb0095","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1126\/science.7939685","article-title":"c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling","volume":"266","author":"Grigoriadis","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.intimp.2017.07.003_bb0100","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10875-009-9316-6","article-title":"Osteoimmunology: cross talk between the immune and bone systems","volume":"29","author":"Nakashima","year":"2009","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.intimp.2017.07.003_bb0105","doi-asserted-by":"crossref","first-page":"35209","DOI":"10.1074\/jbc.M505815200","article-title":"Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine mediated osteoclastogenesis","volume":"280","author":"Kim","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2017.07.003_bb0110","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/edrv.20.3.0367","article-title":"Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families","volume":"20","author":"Suda","year":"1999","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.intimp.2017.07.003_bb0115","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1172\/JCI119679","article-title":"Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor","volume":"100","author":"Abu-Amer","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2017.07.003_bb0120","doi-asserted-by":"crossref","first-page":"31155","DOI":"10.1074\/jbc.M001229200","article-title":"Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesismediated by receptor activator of NF-kappa B ligand (RANKL)","volume":"275","author":"Matsumoto","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2017.07.003_bb0125","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nri2062","article-title":"Osteoimmunology","volume":"7","author":"Takayanagi","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2017.07.003_bb0130","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/nm1197-1285","article-title":"Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2","volume":"3","author":"Iotsova","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2017.07.003_bb0135","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.gene.2005.12.012","article-title":"NFATc1 regulation of the human beta 3 integrin promoter in osteoclast differentiation","volume":"372","author":"Crotti","year":"2006","journal-title":"Gene"},{"issue":"4","key":"10.1016\/j.intimp.2017.07.003_bb0140","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.bbrc.2010.10.103","article-title":"Molecular mechanisms of the inhibitory effect of lipopolysaccharide (LPS) on osteoblast differentiation","volume":"402","author":"Bandow","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576917302692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576917302692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T15:56:12Z","timestamp":1535558172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576917302692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":28,"alternative-id":["S1567576917302692"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2017.07.003","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psoralidin suppresses osteoclastogenesis in BMMs and attenuates LPS-mediated osteolysis by inhibiting inflammatory cytokines","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2017.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}